Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Preferred Shares (2017 - 2019)

Historic Preferred Shares for Aytu Biopharma (AYTU) over the last 3 years, with Q4 2019 value amounting to $1022.0.

  • Aytu Biopharma's Preferred Shares rose 12560.71% to $1022.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $1022.0, marking a year-over-year increase of 12560.71%. This contributed to the annual value of $359.0 for FY2019, which is N/A changed from last year.
  • Aytu Biopharma's Preferred Shares amounted to $1022.0 in Q4 2019, which was up 12560.71% from $315.0 recorded in Q3 2019.
  • Aytu Biopharma's 5-year Preferred Shares high stood at $1022.0 for Q4 2019, and its period low was $1.0 during Q3 2017.
  • Over the past 3 years, Aytu Biopharma's median Preferred Shares value was $315.0 (recorded in 2019), while the average stood at $340.71.
  • Its Preferred Shares has fluctuated over the past 5 years, first surged by 4520000.0% in 2018, then skyrocketed by 12560.71% in 2019.
  • Over the past 3 years, Aytu Biopharma's Preferred Shares (Quarter) stood at $1.0 in 2017, then soared by 45200.0% to $453.0 in 2018, then soared by 125.61% to $1022.0 in 2019.
  • Its Preferred Shares stands at $1022.0 for Q4 2019, versus $315.0 for Q3 2019 and $359.0 for Q2 2019.